Europe Clinical Nutrition Market - Growth, Trends And Forecast 2017 - 2022

  • ID: 4387661
  • Report
  • Region: Europe
  • 105 pages
  • Mordor Intelligence
1 of 3
The European clinical nutrition market has been estimated at USD XX billion in 2016 and is projected to reach USD XX billion by 2021, growing at a CAGR of about X% during the forecast period from 2016 to 2021. Clinical nutrition is an area of medicine that offers treatment of medical disorders caused due to an improper diet or due to the bodyinability to absorb the nutrients available in a normal diet.

Clinical nutrition products include clinical foods and dietary supplements that are categorized primarily as pharmaceuticals and are delivered through enteral and parenteral feeding. They are aimed at treating metabolic disorders, eating or nutritional disorders and others. The clinical nutrition market majorly comprises the geriatric population with weak digestive systems. There is also a good demand for clinical foods for the pediatric population as well.

Europe Clinical Nutrition Market-Market Dynamics

The European clinical nutrition market is driven by the aging population and increased disease diagnosis like cardiovascular diseases, cancer, dementia, and diabetes. Other factors affecting the growth of the market are increased preterm birth rates in high-income countries. However, the market is highly constrained due to the strict FDA regulations and the lack of public awareness on the importance of nutrition. The European clinical nutrition market is growing due to the increased levels of health consciousness among the population. The current trend of mergers and acquisitions between companies offers better opportunities in the market. However, the market is challenged by pricing pressures, competition, and market complexity.

The European clinical nutrition market can be segmented by the type of end-user: infant, child, adult; application: sports nutrition and therapeutic nutrition; ingredients: vitamins, amino acids, minerals and glucose; therapeutic application: diarrhea, cancer, diabetes, renal diseases, and others; and the route of administration: oral, enteral and parenteral.

The European clinical nutrition market has also been geographically segmented into the Benelux, UK, France, Germany, Italy, Spain, Portugal, and Scandinavia, with the UK dominating the European market. France is also an emerging market that has a scope for growth and can potentially dominate the market in the future.

Key Deliverables:

Market analysis for the European clinical nutrition market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the European clinical nutrition market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Characterization
5.1 Current Market Scenario
5.2 Market Overview
5.3 Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis
5.3.1 Market Drivers
5.3.1.1 Ageing Demographic
5.3.1.2 Increasing Incidence of Chronic and Lifestyle-Related Diseases
5.3.1.3 Significant Incidence of Malnutrition
5.3.2 Market Restraints
5.3.2.1 FDA Regulations
5.3.2.2 Lack of Public Awareness
5.3.3 Market Challenges
5.3.3.1 Pricing Pressures
5.3.3.2 Competition
5.3.3.3 Market Complexity
5.3.4 Market Opportunities
5.3.4.1 Increased levels of health consciousness
5.3.4.2 Mergers and Acquisitions
5.4 Clinical Nutrition Market Segmentation
5.4.1 By Applications
5.4.1.1 Infant
5.4.1.2 Child
5.4.1.3 Adult
5.4.1.4 Sports Nutrition
5.4.1.5 Therapeutic Nutrition
5.4.2 By Ingredients
5.4.2.1 Vitamins & Amino acids
5.4.2.2 Minerals
5.4.2.3 Glucose
5.4.3 By Applications
5.4.3.1 Protein Maldigestion
5.4.3.2 Malabsorption
5.4.3.3 Food allergies
5.4.3.4 Diarrhea
5.4.3.5 Cancer
5.4.3.6 Diabetes
5.4.3.7 Short-bowel syndrome
5.4.3.8 GI-tract impairment
5.4.3.9 Acute lung injury( ALI)
5.4.3.10 Acute Respiratory Distress( ARDS)
5.4.4 By Route of Administration
5.4.4.1 Oral
5.4.4.2 Parenteral
5.4.4.3 Enteral
5.4.5 By Geography
5.4.5.1 Europe
5.4.5.1.1 Benelux
5.4.5.1.2 France
5.4.5.1.3 Germany
5.4.5.1.4 Italy
5.4.5.1.5 Spain & Portugal
5.4.5.1.6 Scandinavia
5.4.5.1.7 United Kingdom
5.5 Industry Analysis
5.5.1 Key Trends and Developments
5.5.2 Investment Analysis
5.5.3 PorterFive Forces
5.5.3.1 Bargaining Power of Suppliers
5.5.3.2 Bargaining Power of Consumers
5.5.3.3 Threat of New Entrants
5.5.3.4 Threat of Substitute Products and Services
5.5.3.5 Competitive Rivalry within the Industry
5.6 Competitive Landscape
5.6.1 Key Market Players
5.6.1.1 Abbott Healthcare
5.6.1.1.1 Abbott Healthcare- Business Overview
5.6.1.1.2 Abbott Healthcare- Product and Services Portfolio
5.6.1.1.3 Abbott Healthcare- Deals Landscape
5.6.1.1.4 Abbott Healthcare- SWOT Analysis
5.6.1.2 Nestle Health Sciences
5.6.1.3 Danone medical Nutrition
5.6.1.4 Fresenius Kabi
5.6.1.5 Baxter
5.6.1.6 Nutricia
5.6.2 Merger and Acquisition Analysis
5.6.3 New Product Launches
5.6.4 Agreements, Collaborations & Partnerships
5.7 Analyst Outlook for Investment Opportunities
5.8 Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll